Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronan Bureau

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Proteins|April 15, 2008
Three-dimensional model of the human urotensin-II receptor: docking of human urotensin-II and nonpeptide antagonists in the binding site and comparison with an antagonist pharmacophore modelElodie Lescot, Jana Sopkova-de Oliveira Santos, Nathalie Colloc'h, et al.
Journal of Chemical Information and Modeling|March 27, 2007
Definition of new pharmacophores for nonpeptide antagonists of human urotensin-II. Comparison with the 3D-structure of human urotensin-II and URPElodie Lescot, Jana Sopkova-de Oliveira Santos, Christophe Dubessy, et al.
Chemosphere|February 19, 2014
Acute toxicity of 8 antidepressants: what are their modes of action?Laetitia Minguez, Emilie Farcy, Céline Ballandonne, et al.
Ecotoxicology and Environmental Safety|February 11, 2012
Interpretation of honeybees contact toxicity associated to acetylcholinesterase inhibitorsFabienne Dulin, Marie-Pierre Halm-Lemeille, Sylvain Lozano, et al.
European Journal of Medicinal Chemistry|July 1, 2008
Synthesis of new dipyrrolo- and furopyrrolopyrazinones related to tripentones and their biological evaluation as potential kinases (CDKs1-5, GSK-3) inhibitorsChristophe Rochais, Nghia Vu Duc, Elodie Lescot, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2005
Phenylpyrroles, a new chemolibrary virtual screening class of 5-HT7 receptor ligandsMagalie Paillet-Loilier, Frédéric Fabis, Alban Lepailleur, et al.
Journal of Chemical Information and Modeling|May 27, 2014
Dual histamine H3R/serotonin 5-HT4R ligands with antiamnesic properties: pharmacophore-based virtual screening and polypharmacologyAlban Lepailleur, Thomas Freret, Stéphane Lemaître, et al.
Journal of Medicinal Chemistry|December 28, 2002
New benzo[h][1,6]naphthyridine and azepino[3,2-c]quinoline derivatives as selective antagonists of 5-HT4 receptors: binding profile and pharmacological characterizationAntoine Hinschberger, Sabrina Butt, Véronique Lelong, et al.
Molecular Informatics|July 9, 2024
Navigating pharmacophore space to identify activity discontinuities: A case study with BCR-ABLMaroua Lejmi, Damien Geslin, Ronan Bureau, et al.
Journal of Chemical Information and Modeling|October 11, 2017
Toward Understanding Mcl-1 Promiscuous and Specific Binding ModeJade Fogha, Bogdan Marekha, Marcella De Giorgi, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Proteins|April 15, 2008
Three-dimensional model of the human urotensin-II receptor: docking of human urotensin-II and nonpeptide antagonists in the binding site and comparison with an antagonist pharmacophore modelElodie Lescot, Jana Sopkova-de Oliveira Santos, Nathalie Colloc'h, et al.
Journal of Chemical Information and Modeling|March 27, 2007
Definition of new pharmacophores for nonpeptide antagonists of human urotensin-II. Comparison with the 3D-structure of human urotensin-II and URPElodie Lescot, Jana Sopkova-de Oliveira Santos, Christophe Dubessy, et al.
Chemosphere|February 19, 2014
Acute toxicity of 8 antidepressants: what are their modes of action?Laetitia Minguez, Emilie Farcy, Céline Ballandonne, et al.
Ecotoxicology and Environmental Safety|February 11, 2012
Interpretation of honeybees contact toxicity associated to acetylcholinesterase inhibitorsFabienne Dulin, Marie-Pierre Halm-Lemeille, Sylvain Lozano, et al.
European Journal of Medicinal Chemistry|July 1, 2008
Synthesis of new dipyrrolo- and furopyrrolopyrazinones related to tripentones and their biological evaluation as potential kinases (CDKs1-5, GSK-3) inhibitorsChristophe Rochais, Nghia Vu Duc, Elodie Lescot, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2005
Phenylpyrroles, a new chemolibrary virtual screening class of 5-HT7 receptor ligandsMagalie Paillet-Loilier, Frédéric Fabis, Alban Lepailleur, et al.
Journal of Chemical Information and Modeling|May 27, 2014
Dual histamine H3R/serotonin 5-HT4R ligands with antiamnesic properties: pharmacophore-based virtual screening and polypharmacologyAlban Lepailleur, Thomas Freret, Stéphane Lemaître, et al.
Journal of Medicinal Chemistry|December 28, 2002
New benzo[h][1,6]naphthyridine and azepino[3,2-c]quinoline derivatives as selective antagonists of 5-HT4 receptors: binding profile and pharmacological characterizationAntoine Hinschberger, Sabrina Butt, Véronique Lelong, et al.
Molecular Informatics|July 9, 2024
Navigating pharmacophore space to identify activity discontinuities: A case study with BCR-ABLMaroua Lejmi, Damien Geslin, Ronan Bureau, et al.
Journal of Chemical Information and Modeling|October 11, 2017
Toward Understanding Mcl-1 Promiscuous and Specific Binding ModeJade Fogha, Bogdan Marekha, Marcella De Giorgi, et al.
Pageof 7